Current diagnosis and management of erectile dysfunction
- PMID: 31099420
- DOI: 10.5694/mja2.50167
Current diagnosis and management of erectile dysfunction
Abstract
Erectile dysfunction (ED) is a common male sexual dysfunction associated with a reduced quality of life for patients and their partners. ED is associated with increasing age, depression, obesity, lack of exercise, diabetes mellitus, hypertension, dyslipidaemia, cardiovascular disease and lower urinary tract symptoms related to benign prostatic hyperplasia. The evaluation of men with ED requires a full medical and personally and culturally sensitive sexual history, a focused clinical examination, fasting glucose levels, a fasting lipid profile and, in select cases, a total testosterone level and a prostate-specific antigen test. Treatment of ED requires lifestyle modification, reduction of comorbid vascular risk factors, and treatment of organic or psychosexual dysfunction with either pharmacotherapy alone or in combination with psychosexual therapy. Between 60% and 65% of men with ED, including those with hypertension, diabetes mellitus, spinal cord injury and other comorbid medical conditions, can successfully complete intercourse in response to the phosphodiesterase type 5 inhibitors (PDE5i) sildenafil, tadalafil, vardenafil and avanafil. Patient-administered intracorporal injection therapy using vasodilator drugs such as alprostadil is an effective treatment and is useful in men who fail to respond to oral pharmacological agents. Surgical treatment of ED with multicomponent inflatable penile implants is associated with high satisfaction rates. Penile arterial revascularisation and venous ligation surgery are associated with relatively poor outcome results in men with penile atherosclerotic disease or corporal veno-occlusive dysfunction.
Keywords: Sexual dysfunction.
© 2019 AMPCo Pty Ltd.
Comment in
-
Current diagnosis and management of erectile dysfunction.Med J Aust. 2020 Feb;212(2):95-95.e1. doi: 10.5694/mja2.50450. Epub 2019 Dec 9. Med J Aust. 2020. PMID: 31816101 No abstract available.
Similar articles
-
New treatment options for erectile dysfunction in patients with diabetes mellitus.Drugs. 2004;64(23):2667-88. doi: 10.2165/00003495-200464230-00004. Drugs. 2004. PMID: 15537369 Review.
-
[New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].Herz. 2003 Jun;28(4):314-24. doi: 10.1007/s00059-003-2472-1. Herz. 2003. PMID: 12825147 Review. German.
-
Management of erectile dysfunction.Am Fam Physician. 2010 Feb 1;81(3):305-12. Am Fam Physician. 2010. PMID: 20112889 Review.
-
Evaluation and medical management of erectile dysfunction.Mayo Clin Proc. 2006 Mar;81(3):385-90. doi: 10.4065/81.3.385. Mayo Clin Proc. 2006. PMID: 16529142 Review.
-
Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.J Sex Med. 2007 Jan;4(1):166-175. doi: 10.1111/j.1743-6109.2006.00402.x. J Sex Med. 2007. PMID: 17233782 Clinical Trial.
Cited by
-
The association between uric acid and erectile dysfunction in US adults: NHANES 2001-2004.BMC Nephrol. 2024 Jun 3;25(1):189. doi: 10.1186/s12882-024-03621-y. BMC Nephrol. 2024. PMID: 38831443 Free PMC article.
-
The relationship between social support and erectile dysfunction in middle-aged and older males.Front Public Health. 2024 May 9;12:1332561. doi: 10.3389/fpubh.2024.1332561. eCollection 2024. Front Public Health. 2024. PMID: 38784589 Free PMC article.
-
Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 Apr 4;15:1368079. doi: 10.3389/fendo.2024.1368079. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38638136 Free PMC article.
-
Evaluation of efficacy and safety profile of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film in men with mild-to-moderate erectile dysfunction: a comparative placebo-controlled study.Int Urol Nephrol. 2024 Mar 4. doi: 10.1007/s11255-024-04003-x. Online ahead of print. Int Urol Nephrol. 2024. PMID: 38433177
-
Association of METS-IR index with prevalence of erectile dysfunction in US adults: a cross-sectional study.Int Urol Nephrol. 2024 Jul;56(7):2157-2164. doi: 10.1007/s11255-024-03961-6. Epub 2024 Feb 25. Int Urol Nephrol. 2024. PMID: 38403823
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical